1702 related articles for article (PubMed ID: 16391411)
21. [Modern policy of anti-helicobacter therapy of ulcer disease].
Ryss ES
Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
[No Abstract] [Full Text] [Related]
22. [The Nobel Prize in Physiology or Medicine for 2005 for the discovery of the stomach bacterium Helicobacter pylori].
Kleibeuker JH; Thijs JC
Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2955-7. PubMed ID: 16425846
[TBL] [Abstract][Full Text] [Related]
23. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
24. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
[TBL] [Abstract][Full Text] [Related]
25. This year's Nobel Prize to gastroenterology: Robin Warren and Barry Marshall awarded for their discovery of Helicobacter pylori as pathogen in the gastrointestinal tract.
Hellstrom PM
World J Gastroenterol; 2006 May; 12(19):3126-7. PubMed ID: 16718802
[No Abstract] [Full Text] [Related]
26. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
Robinson M
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
[TBL] [Abstract][Full Text] [Related]
27. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
[TBL] [Abstract][Full Text] [Related]
28. A humble bacterium sweeps this year's Nobel Prize.
Mégraud F
Cell; 2005 Dec; 123(6):975-6. PubMed ID: 16360024
[No Abstract] [Full Text] [Related]
29. [VIII Congress of Russian Gastroenterological Scientific Society. XXXIV Session of the Central Research Institute of Gastroenterology (4-7 March, 2008, Moscow). Standards "Diagnosis and therapy of acid-dependent diseases including Helicobacter pylori-associated diseases" (Third Moscow Agreement, 04.02.05 with supplements adopted on 06.03.08 by VIII Congress of Russian Gastroenterological Scientific Society)].
; Bredikhina NA; Butov MA; Vasil'ev IuV; Golovanova ES; Grigor'ev PIa; Grinevich VB; Ivanikov IO; Isakov VA; Kalinin AV; Lazebnik LB; Loginov FF; Maev IV; Miller DA; Minushkin ON; Nizov AA; Panov AA; Pasechnikov VD; Sadokov VM; Simonenkov VI; Tkachenko EI; Uspenskiĭ VP; Tsukanov VV; Chernin VV; Chernyshev VL; Shcherbakov PL; Iakovenko EP
Eksp Klin Gastroenterol; 2008; (3):130-4. PubMed ID: 19145893
[No Abstract] [Full Text] [Related]
30. [Nobel [corrected] prize for the discoverers of Helicobacter pylori--the overlooked bacteria].
Levine H
Harefuah; 2005 Nov; 144(11):755-8, 824. PubMed ID: 16358646
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
32. [Reflections on the Nobel prize, the Helicobacter pylori, the peptic ulcer and the scientific paradigms].
López Vidal Y; Ponce de León S
Rev Invest Clin; 2006; 58(1):6-8. PubMed ID: 16789594
[No Abstract] [Full Text] [Related]
33. Gastric ulcer treatment: cure of Helicobacter pylori infection without subsequent acid-suppressive therapy: is it effective?
van Zanten SV; van der Knoop B
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):489-91. PubMed ID: 18467903
[TBL] [Abstract][Full Text] [Related]
34. The Nobel Prize in 2005 for the discovery of Helicobacter pylori: implications for child health.
Zetterström R
Acta Paediatr; 2006 Jan; 95(1):3-5. PubMed ID: 16373288
[TBL] [Abstract][Full Text] [Related]
35. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of stomach ulcer].
Hudziak H
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S136-S142. PubMed ID: 8734382
[No Abstract] [Full Text] [Related]
37. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Chassany O; Bergmann JF
Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
[No Abstract] [Full Text] [Related]
38. [Helicobacter pylori, the story so far].
D'Elios MM
Med Secoli; 2007; 19(2):641-5. PubMed ID: 18450040
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication--understandable caution but no excuse for inertia.
de Boer WA
Aliment Pharmacol Ther; 1995 Feb; 9(1):85-6. PubMed ID: 7766750
[No Abstract] [Full Text] [Related]
40. Prevention of the rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression.
Kikkawa A; Iwakiri R; Ootani H; Ootani A; Fujise T; Sakata Y; Amemori S; Tsunada S; Sakata H; Koyama T; Fujimoto K
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():79-84. PubMed ID: 15943852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
